OPKO Health Inc (NASDAQ:OPK)

3.72
Delayed Data
As of May 21
 -0.27 / -6.77%
Today’s Change
2.66
Today|||52-Week Range
7.25
-24.08%
Year-to-Date
No recent news for OPKO Health Inc.

Today’s Trading

Previous close3.99
Today’s open4.07
Day’s range3.63 - 4.11
Volume8,338,069
Average volume (3 months)5,182,606
Market cap$2.7B
Data as of 4:00pm ET, 05/21/2018

Growth & Valuation

Earnings growth (last year)-1,000.00%
Earnings growth (this year)+1.28%
Earnings growth (next 5 years)+52.05%
Revenue growth (last year)-12.62%
P/E ratioNM
Price/Sales2.57
Price/Book1.42

Competitors

 Today’s
change
Today’s
% change
PTLAPortola Pharmaceutic...-0.41-0.99%
PBYIPuma Biotechnology I...-1.75-3.24%
CLVSClovis Oncology Inc-0.35-0.70%
MNKMallinckrodt Plc+0.19+1.21%
Data as of 4:01pm ET, 05/21/2018

Financials

Next reporting dateAugust 7, 2018
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$1.1B
Annual profit (last year)-$308.9M
Net profit margin-28.93%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Phillip Frost
Chief Financial Officer &
Senior Vice President
Adam E. Logal
Corporate headquarters
Miami, Florida

Forecasts